Six More Cases Settle in Bogus Acai Berry Weight Loss Claims

January 27, 2012 -- Perhaps now there will be fewer fake “news sites” on the internet promoting expensive products that don’t work. The U.S. Federal Trade Commission (FTC) is forcing six men to pay around $500,000 because they ran deceptive...

FDA’s New Dietary Supplement Guidelines are Inadequate, Doctor Says

The New England Journal of Medicine has published an editorial by Dr. Pieter Cohen, who argues that the U.S. Food and Drug Administration (FDA) guidelines proposed in July 2011 do not go far enough to regulate new ingredients in dietary...

Transvaginal Mesh Safety Information and History

There is growing concern regarding the safety of transvaginal mesh after researchers found that the implants have a 15% rate of complications.

Ibuprofen, Diclofenac May Increase Risk of Heart Attack, Stroke, Death

January 25, 2012 --A new study has found that common painkillers may significantly increase a user’s risk of heart attacks, strokes, and death from heart disease. The risk is not significant if you take the pills occasionally or only for...

Texas Prozac PPHN Lawsuit

New research has found that women who take an SSRI antidepressant late in pregnancy may double their baby’s risk of suffering PPHN at birth, which can lead to life-threatening complications. Prozac Overview Prozac (fluoxetine) is a medication in a class...

Texas Tysabri Lawsuit

Tysabri (natalizumab) is associated with hundreds of cases of Progressive Multifocal Leukoencephalopathy (PML), which is a life-threatening brain infection caused by the JC virus. UPDATE: At least 6 Tysabri PML Lawsuits Filed Against Biogen Idec, Inc. September 18, 2013 --...

Texas Gilenya Lawyer

Gilenya is a multiple sclerosis medication used by roughly 30,000 people worldwide. Recently, it has been linked to the deaths of 11 people worldwide, which has prompted the FDA to launch an investigation. Several patients died of heart troubles shortly...

FDA Warning Letter for DePuy’s Custom Implants

January 19, 2012 -- The FDA is warning DePuy Orthopaedics Inc. that it is violating the law by selling its “custom” synthetic hip, knee, and ankle replacements without FDA approval. The FDA warning letter has resulted in DePuy halting sales...

New Clinical Trial of Multaq Moves Forward

January 19, 2012 -- Yet another clinical trial of Multaq (dronedarone) is set to move forward, despite the Multaq lawsuits brought against the drug-company by people who contacted a Multaq lawyer following serious, life-threatening side effects. Though the medication has...